PERISCOPE: road towards effective control of pertussis.
Details
Serval ID
serval:BIB_3850F0D40112
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
PERISCOPE: road towards effective control of pertussis.
Journal
The Lancet. Infectious diseases
Working group(s)
PERISCOPE Consortium
Contributor(s)
Mills KHG, Kester K.E., Kampmann B., Silerova M., Heininger U., van Dongen JJM, van der Most R.G., Huijnen M.A., Siena E., Mielcarek N., Ochs M.M., Denoël P., Berbers G., Buisman A.M., de Jonge M.I., Fenwick C., Gorringe A., He Q., Kelly D., Le Grand R., Locht C., Mascart F., Mertsola J., Orfao A., Pantaleo G., Pollard A.J., Preston A., Read R., Sebo P., van Els C., Vecerek B., Londoño-Hayes P., de Groot R.
ISSN
1474-4457 (Electronic)
ISSN-L
1473-3099
Publication state
Published
Issued date
05/2019
Peer-reviewed
Oui
Volume
19
Number
5
Pages
e179-e186
Language
english
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Abstract
The resurgence and changing epidemiology of pertussis in high-income countries, the high infant mortality caused by pertussis in low-income countries, and the increasing morbidity in all age groups worldwide call for a concerted effort to both improve the current vaccines and develop new vaccines and vaccination strategies against pertussis. In this Personal View, we identify several key obstacles on the path to developing a durable solution for global control of pertussis. To systematically address these obstacles, the PERtussIS Correlates Of Protection Europe (PERISCOPE) Consortium was established in March, 2016. The objectives of this consortium are to increase scientific understanding of immunity to pertussis in humans induced by vaccines and infections, to identify biomarkers of protective immunity, and to generate technologies and infrastructure for the future development of improved pertussis vaccines. By working towards the accelerated licensure and implementation of novel, well tolerated, and effective pertussis vaccines, we hope to strengthen and stimulate further collaboration and transparency between the key stakeholders, including the public, the scientific community, public health institutes, regulatory authorities, and vaccine manufacturers.
Keywords
Animals, Bibliometrics, Biomarkers, Bordetella pertussis/drug effects, Bordetella pertussis/immunology, Bordetella pertussis/pathogenicity, Carrier State, Drug Evaluation, Preclinical, Europe/epidemiology, Humans, Immunity, Cellular/drug effects, Immunity, Humoral/drug effects, Immunogenicity, Vaccine, Incidence, International Cooperation, Pertussis Vaccine/administration & dosage, Pertussis Vaccine/biosynthesis, Vaccination/methods, Whooping Cough/epidemiology, Whooping Cough/immunology, Whooping Cough/prevention & control, Whooping Cough/transmission
Pubmed
Web of science
Create date
23/05/2024 13:25
Last modification date
05/09/2024 9:00